Arrowhead Pharmaceuticals Inc (ARWR)

Gross profit margin

		Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020
Gross profit	US$ in thousands	-113,885	117,367	108,379	49,039	29,774
Revenue	US$ in thousands	3,471	222,409	243,231	138,287	87,992
Gross profit margin		-3,281.04%	52.77%	44.56%	35.46%	33.84%

September 30, 2024 calculation

Gross profit margin = Gross profit ÷ Revenue
= $-113,885K ÷ $3,471K
= -3,281.04%

The gross profit margin of Arrowhead Pharmaceuticals Inc has fluctuated over the past five years, ranging from negative to positive values. Notably, the company experienced a significant negative gross profit margin of -3,281.04% as of September 30, 2024, which may indicate potential issues with cost management or pricing strategies. In contrast, the gross profit margin showed improvement in the prior years, with 52.77% in 2023, 44.56% in 2022, 35.46% in 2021, and 33.84% in 2020. This suggests that Arrowhead Pharmaceuticals Inc has historically been able to generate a reasonable level of gross profit relative to its revenues, although the negative margin in 2024 is a cause for concern and warrants further investigation into the company's financial performance and operational efficiency.